US FDA and Health Canada: Joint Regional Consultation on the ICH
FDA and Health Canada will cohost a regional public meeting entitled ‘‘United States Food and Drug Administration and Health Canada Joint Regional Consultation on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)’’ to provide information and receive comments on the current activities of ICH as well as the upcoming meetings in Kobe, Japan scheduled for June 4 through 7, 2018. The topics for discussion include the current ICH guideline topics under development that will be discussed at the forthcoming ICH Assembly Meeting in Kobe – see agenda for list of discussion topics. The purpose of this public meeting is to solicit public input prior to the next ICH Assembly meeting and expert working group meetings in Kobe.
April 6, 2018
10:00 a.m. to 1:00 p.m. ET
10903 New Hampshire Ave. Bldg 31 Conference Center, Rm. 1503 (Great Room) Silver Spring, MD 20993, USA Or Webcast (A website to access the webcast will be emailed to those who register for the meeting as a remote attendee – see Registration for details)
Webcast (A website to access the webcast will be emailed to those who register for the meeting as a remote attendee – see Registration for details)
If you wish to attend the public meeting either in-person or via webcast, please register at the following website: https://ich_regional_consultation_2018.eventbrite.com . Registrations may be limited, so early registration is recommended. Registration is free and will be on a first-come, first-served basis. However, the number of participants from each organization may be limited based on space limitations. Registrants will receive confirmation once they have been accepted.
For more information: please contact Amanda.Roache@fda.hhs.gov.